#nonsmallcelllungcancer — Public Fediverse posts

https://www.europesays.com/britain/134258/ Hutchmed, AstraZeneca Submit Lung Cancer Drug Application for ORPATHYS-TAGRISSO Combination to U.S. FDA — BigGo Finance #AstraZeneca #ChengTzeFung #Hutchmed #NonSmallCellLungCancer #Orpathys #SAFFRONStudy #Tagrisso #USFoodAndDrugAdministration

https://www.europesays.com/britain/132372/ AstraZeneca ends phase 3 cancer trial as bispecific underwhelms #AstraZeneca #biotech #BispecificAntibodies #ClinicalData #FailedTrials #FierceBiotechHomepage #ImmunoOncology #NonSmallCellLungCancer

https://www.europesays.com/britain/130881/ GSK pens $1.3B Hutchmed deal for KRAS-EGFR cancer asset #biotech #BiotechDeals #ColorectalCancer #FierceBiotechHomepage #GSK #Hutchmed #KRAS #NonSmallCellLungCancer

https://www.europesays.com/ie/685249/ MD Anderson trial challenges local consolidative therapy paradigm in NSCLC #cancer #Cell #chemotherapy #Éire #Health #IE #immunotherapy #Ireland #LungCancer #NonSmallCellLungCancer #SmallCellLungCancer #Surgery #therapy #Tumor

https://www.europesays.com/ie/648665/ Younger lung cancer patients show more targetable gene alterations #cancer #Cell #Éire #Genetic #Genomic #Health #IE #Ireland #LungCancer #medicine #NonSmallCellLungCancer #PrecisionMedicine #Research #SmallCellLungCancer #Tumor

https://www.europesays.com/britain/105261/ AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure #AntibodyDrugConjugates #AstraZeneca #ClinicalData #DaiichiSankyo #EGFRMutatedLungCancer #Enhertu #FiercePharmaHomepage #HER2 #Hutchmed #METInhibitor #NonSmallCellLungCancer #Pharma #savolitinib #Tagrisso

https://www.europesays.com/britain/105230/ AstraZeneca axes NSCLC trial after bispecific deemed unlikely to best Keytruda #AstraZeneca #bispecific #blockbuster #GlobalData #IndependentDataMonitoringCommittee #Keytruda #NonSmallCellLungCancer #Patients #PhaseIIITrial #ProgressionFreeSurvival

https://www.europesays.com/britain/105007/ AstraZeneca Halts Lung Cancer Trial for Volrustomig; Reports Positive Data for Tagrisso Combo, Enhertu #AstraZeneca #CervicalCancer #CombinationTreatment #LungCancer #NonSmallCellLungCancer #Phase3Trial

Wait, you had cancer….

What is one question you hate to be asked? Explain.

I hear so many different things because my body and I do not agree. The only time I was at a healthy weight was when I was younger and I worked out 3 to 4 hours a day because I had been a varsity swimmer. I continued that into college but not on a team. I just worked out a lot. Until I just couldn’t. Something happened that I became exhausted. I didn’t function. It happened back in High School too. I knew something was wrong. At 21 I was diagnosed with Lung Cancer.

I went to the doctor. I grabbed his arm as he thought it was nothing. I said “I know something is really wrong.” He chose to do a scan just to ease my mind. Something showed. The specialist was determined it was nothing. 9 months later and a dozen scans later that same doctor that just did a scan to ease my mind demanded what we all needed done. The biopsy. Finally the specialist agreed and that specialist was 100% wrong and I was 100% right that something was wrong.

It was insitu. No chemo, no radiation just surgery that almost killed me. It left me constantly trying to find the new me. But I now had a permanent physical disability. My prior self that loved to workout still struggles 23 years later and 120 pounds heavier. The thing is this question never leads to anything more than “Im so sorry” or for those that despise me at sime point is “maybe you should have just died”. The thing is who i was did die. I am constantly finding myself. A new version. One trying to have a healthy body. One that can continue to survive as my body still continues to throw me curve balls. From PCOS, insulin resistance that turned to diabetes and now psoriasis that covers 40% of my body.

Finding correct doctors that can treat issues and not just pass them off as “just deal with it” becomes impossible.

This question of “you had cancer?” Never gets to the deep conversations it should. What did it do to you? How did you cope? Or anything that leads to a deep conversation. Most of my own family only talks about what it did to them not ever asking what my cancer did to me. It was mine. I had it. They were just a witness.

https://www.europesays.com/britain/102744/ Nuvalent deal delivers GSK’s first-ever lung cancer approval #DrugApprovals #FDAApproval #FDAApprovals #FiercePharmaHomepage #GSK #LungCancer #marketing #NonSmallCellLungCancer #Pharma #ROS1

https://www.europesays.com/ch/112589/ Genprex partners with Roche Diagnostics on biomarker validation for NSCLC #ClinicalTrials #Genprex #NonSmallCellLungCancer #Roche #RocheDiagnostics #ValidationStudies

https://www.europesays.com/ch/111297/ Genprex Shares Rise After Collaboration With Roche Diagnostics #AssayValidation #BiotechnologyCompany #ClinicalResearch #GenprexInc #MedicalResearch #NonSmallCellLungCancer #PatientSelection #patients #preclinical #Roche #RocheDiagnostics

https://www.europesays.com/britain/88972/ GSK Lands FDA Approval for Nuvalent-Acquired Jideytro for NSCLC #FDA #GSK #GSKPlc #Jideytro #NeurocrineBiosciences #NonSmallCellLungCancer #ZacksInvestmentResearch #ZacksRank

https://www.europesays.com/britain/88582/ $10B M&A Deal Pays Off With GSK’s First Lung Cancer Drug Approval #BiopharmaNl #Cancer #ClinicalTrials #FDA #GSK #LungCancer #NonSmallCellLungCancer #Nuvalent #SpotlightPayeropp

https://www.europesays.com/britain/82757/ AstraZeneca licenses lung cancer drug Zegfrovy | AZN SEC Filing #AstraZeneca #AZN #EGFRExon20 #LicenseAgreement #NonSmallCellLungCancer #OncologyDrug #RoyaltyDeal #Sunvozertinib #Zegfrovy

https://www.europesays.com/britain/82620/ AstraZeneca to license lung cancer drug from China’s Dizal Pharmaceutical #AstraZeneca #ClinicalTrials #DizalPharmaceutical #LungCancerTreatment #NonSmallCellLungCancer #ProgressionFreeSurvival #Sunvozertinib #Zegfrovy

https://www.europesays.com/britain/82602/ AstraZeneca to license lung cancer drug from China’s Dizal Pharmaceutical #AstraZeneca #ClinicalTrials #DizalPharmaceutical #LungCancerTreatment #NonSmallCellLungCancer #ProgressionFreeSurvival #Sunvozertinib #Zegfrovy

https://www.europesays.com/ch/97049/ With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs #BiopharmaNl #cancer #ClinicalTrials #divarasib #KRASG12C #LungCancer #NonSmallCellLungCancer #Roche

https://www.europesays.com/britain/75211/ Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC #AstraZeneca #CombinationTherapy #EGFRTKI #NonSmallCellLungCancer #Patients #PDL1 #therapeutics

https://www.europesays.com/britain/74955/ AstraZeneca and Abbisko collaborate on NSCLC combination therapy trial #AstraZeneca #combination #NationalMedicalProductsAdministration #NonSmallCellLungCancer

https://www.europesays.com/ch/95774/ Roche divarasib tops KRAS G12C lung cancer drugs #divarasib #KRASG12C #Krascendo1 #NonSmallCellLungCancer #Oncology #PhaseIII #RHHBY #Roche

https://www.europesays.com/ch/86592/ As Roche eyes busy 2026, Vabysmo undershoots targets and Tecentriq fails early lung cancer study #BreastCancer #BTKInhibitors #ClinicalData #Earnings #FiercePharmaHomepage #financials #MultipleSclerosis #NonSmallCellLungCancer #PD1/L1 #Pharma #Roche #Tecentriq #TeresaGraham #Vabysmo #WetAMD

https://www.europesays.com/britain/61006/ GSK and NUVL Stocks Put Biotech M&A and Patent Cliff Deals in Focus for Investors #BigPharmaAcquisition #BiotechM&A #GSK #KinaseInhibitor #NonSmallCellLungCancer #NuvalentAcquisition #NUVL #OncologyBuyout #PharmaceuticalPatentCliff #ShortSqueeze

https://www.europesays.com/ch/81170/ GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer #ALK #biotech #Deals #FierceBiotechHomepage #GSK #MergersAndAcquisitions #NonSmallCellLungCancer #Nuvalent #Roche #ROS1

https://www.europesays.com/britain/60400/ GSK to Acquire Nuvalent for $10.6B, Boosting Cancer Pipeline with Precision NSCLC Treatments #AndTherapeutics #Cancer #cancers #diagnosis #DrugDevelopment(researchAndDevelopment) #FdaReview #GenEdge #GSK #IndustryNews #LungCancer #medicine #News #NonSmallCellLungCancer #Nuvalent #OrganonInternational #pfizer #RegulatoryPolicies #ResearchAndDevelopment #RoyaltyPharma #shionogi #SunPharmaceuticalIndustries #SystemicConditions

https://www.europesays.com/britain/60389/ GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer #ALK #biotech #Deals #FierceBiotechHomepage #GSK #MergersAndAcquisitions #NonSmallCellLungCancer #Nuvalent #ROS1

https://www.europesays.com/britain/59814/ GSK Buys Nuvalent To Deepen Oncology Focus And Future Lung Cancer Revenue #acquisition #GSK #LungCancer #NonSmallCellLungCancer #Nuvalent #TyrosineKinaseInhibitors

https://www.europesays.com/britain/59553/ GSK Gets a Pair of Near-Commercial Lung Cancer Drugs via $10.6B Nuvalent Acquisition #BiopharmaNl #Deals #GSK #LungCancer #MergersAndAcquisitions #NonSmallCellLungCancer #Nuvalent

https://www.europesays.com/britain/59069/ Britain’s GSK buys US cancer firm Nuvalent for $10.6 billion in its second-largest deal ever #BiotechAcquisitionNews #CancerDrugDevelopment #FDAReviewDrugs #GSK #GSKAcquisition #GSKBuysNuvalent #GSKCancerPortfolio #GSKNuvalentDeal #GSKOncologyBusiness #LungCancerTreatments #neladalkib #NonSmallCellLungCancer #NSCLCDrugs #NuvalentAcquisition #PharmaceuticalMergers #zidesamtinib

https://www.europesays.com/ch/65474/ Roche brings 7-minute lung cancer shot to India #DCGIApproval #immunotherapy #LungCancerTreatment #NonSmallCellLungCancer #Roche #RochePharmaIndia #SubcutaneousInjection #Tecentriq

https://www.europesays.com/uk/876706/ Nuvation Bio Inc. (NUVB) Turns Bullish amid Positive Regulatory Trajectory in Europe #EU #Europe #European #EuropeanMarket #EuropeanMedicinesAgency #NonSmallCellLungCancer #NuvationBio #NuvationBioInc #PennyStocks #RegulatoryApproval

https://www.europesays.com/uk/847558/ AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial #Biomedicine #CancerResearch #ComputationalModels #general #Health #Healthcare #InfectiousDiseases #MedicalImaging #MetabolicDiseases #MolecularMedicine #Neurosciences #NonSmallCellLungCancer #OutcomesResearch #RespiratorySignsAndSymptoms #UK #UnitedKingdom

https://www.europesays.com/ie/401666/ AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial #Biomedicine #CancerResearch #ComputationalModels #Éire #general #Health #HealthCare #Healthcare #IE #InfectiousDiseases #Ireland #MedicalImaging #MetabolicDiseases #MolecularMedicine #Neurosciences #NonSmallCellLungCancer #OutcomesResearch #RespiratorySignsAndSymptoms

https://www.europesays.com/ie/314322/ Additional lymph node evaluation needed during surgery to accurately identify lung cancer spread #cancer #Cell #Éire #Health #IE #imaging #Ireland #LungCancer #LymphNode #LymphNodes #Metastasis #NonSmallCellLungCancer #Research #SmallCellLungCancer #Surgery

https://www.europesays.com/ie/297110/ Understanding tumor growth patterns helps guide treatment after lung cancer #cancer #CancerTreatment #Cell #chemotherapy #Éire #Health #IE #immunotherapy #Ireland #LungCancer #medicine #NonSmallCellLungCancer #Pharmacology #PublicHealth #Research #SmallCellLungCancer

https://www.europesays.com/ie/198886/ Development of a bispecific antibody that inhibits EGFR and B7H3 in NSCLC | Biomarker Research #B7H3/CD276 #Biomedicine #BispecificAntibody #CancerResearch #EGFR #Éire #general #IE #Ireland #NonSmallCellLungCancer #Technology

https://www.europesays.com/ie/141703/ How COVID mRNA vaccines may make cancer treatments more effective #cancer #Cell #Cold #CoronavirusDiseaseCOVID19 #Covid19 #Cytokines #Éire #Health #heat #IE #ImmuneSystem #immunotherapy #Interferon #Ireland #LungCancer #Melanoma #NonSmallCellLungCancer #PDL1 #Preclinical #Receptor #SARS #SarsCov2 #skin #SmallCellLungCancer #therapy #Tumor #Vaccine

https://www.europesays.com/uk/342267/ Clone copy number diversity is linked to survival in lung cancer #ComputationalModels #Genetics #HumanitiesAndSocialSciences #multidisciplinary #NonSmallCellLungCancer #Phylogeny #Science #UK #UnitedKingdom

First UK Lung Cancer Patient receives mRNA vaccine BNT116  
BNT116 and LungVax are nucleic acid lung cancer vaccine candidates – the former is based on mRNA technology similar to “COVID-19 mRNA vaccines” such...........
#BNT116 #Cancer #DNAVaccine #Lungcancer #LungVax #mRNAVaccine #nonsmallcelllungcancer #NSCLC #UK #Vaccine
Umesh Prasad

https://www.scientificeuropean.co.uk/medicine/first-uk-lung-cancer-patient-receives-mrna-vaccine-bnt116/

#lungcancer #lungcancerawareness #lungcancerawarenessmonth #lungcancerawerness #lungcancerresearch #malignancy #cancer #oncology #smallcelllungcancer #nonsmallcelllungcancer #SCLC #NSCLC #thoracictumors #thoraciconcology #precisiononcology #precisionmedicine #whiteribbonproject #lcsm #breastcancersurvivorship #cancersurvivorship #breastcancer #oncology

#lungcancer #lungcancerawareness #lungcancerawarenessmonth #lungcancerawerness #lungcancerresearch #malignancy #cancer #oncology #smallcelllungcancer #nonsmallcelllungcancer #SCLC #NSCLC #thoracictumors #thoraciconcology #precisiononcology #precisionmedicine #whiteribbonproject #lcsm #breastcancersurvivorship #cancersurvivorship #breastcancer #oncology #immunology #immunotherapy #genetherapy #cancer #cancerawareness